Uncategorised - European Medical Journal

Imaging Data Poses the Question: Is COVID-19 More Than a Lung Infection?

Imaging Data Poses the Question: Is COVID-19 More Than a Lung Infection?

RAISED blood levels of D-dimer have been strongly associated with poor prognosis of coronavirus causing experts to investigate and provide guidance…

Jonathan Sackier and Steven D. Wexner Interview: ICDS

Dr Jonathan Sackier sat down with Prof Steve Wexner, organiser of the highly successful 2020 International Colorectal DIsease Symposium in Jerusalem…

Sebaceous Carcinoma: A Rare Extraocular Presentation of the Cheek

Sebaceous carcinoma is a rare and very aggressive malignant skin cancer of the sebaceous gland. While sebaceous glands are present all over the body…

Best supporting role: patient organisations

In pharma’s bid to be patient centric, it must bring the patient voice to the drug development process with the help of medical affairs.

Integrating wellness into pharma's patient approach

The transition from reactive to proactive treatments correlates with society’s new-found focus on well-being, and the pharma industry must embrace wellness and adapt to steamroll this into improved overall outcomes for patients.

30th April 2020

An Interview with Prof Alberto Arezzo at UEG Week Barcelona 2019

We spoke to Prof Alberto Arezzo (UEG Scientific Committee Member) at UEG Week 2019, Barcelona, Spain, where he discussed developments in surgical…

Patient Data: Opting In or Out?

At one point in time, our world’s most valuable commodity was oil. Fast forward to the digital age and that accolade is held by data. Free-flowing rivers of it double up as life sources that all industries, including the pharmaceutical industry, have become dependent on. However, as consumers learn the true value of their own information, the broken dam of data is patched up with privacy laws.

29th April 2020

An Interview with Rodrigo Gribble from AstraZeneca

We met with Rodrigo Gribble, Vice President, Cardiovascular, AstraZeneca, who discussed his experience working with emerging markets, the recent successes…

Managing Follicular Lymphoma

28th April 2020

Practical Insights into Managing Follicular Lymphoma: What’s Best for Patients?

The first case focussed on a 56-year-old female economist, who presented with abdominal discomfort that led to a CT scan evaluation where lymph node…

Talking to Emma Clayton

Emma Clayton, CEO, Grey Bear Consultancy, talks about the journey to starting her own agency, pharma communications in the COVID-19 era, and empowering women to succeed in the workplace.